Buy Reliance Infra, Sell Aurobindo Pharma: Jay Thakkar
Nifty is trading in a range between 8,250 and 8,400 and it is difficult to say which way the Nifty will breakout. This is the view of Jay Thakkar, senior technical analyst with Sharekhan. Once it breaks out on either side it would be prudent take a positional call and at current juncture index trading should be avoided, he adds.Â
Stock Talk
Buy HDIL: Investors can buy this stock for target of Rs 175 and dips should also be used as a buying opportunity.
Buy Cadila Healthcare: The stock has corrected significantly and it is good time to accumulate Cadila. This stock can go up and test its previous high as well.
Sell Aurobindo Pharma: The chart set-up is not looking good. Traders should go short on this stock with stop-loss at Rs 822 for target price of Rs 650.
Buy Cipla: Investors should look to buy this stock on dips for target of Rs 575-600.
Buy Reliance Infrastructure: The stock has bottomed out on charts and has important support at Rs 520-525. It can go up to levels of Rs 610-620.
Â
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
